Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Assets
Cash and cash equivalents
Restricted cash
Mortgage servicing rights at fair value
Advances and other receivables, net of reserves of $116 and $112, respectively
Mortgage loans held for sale at fair value
Property and equipment, net of accumulated depreciation of $144 and $157, respectively
Deferred tax assets, net
Other assets
Total assets
Liabilities and Stockholders’ Equity
Unsecured senior notes, net
Advance, warehouse and MSR facilities, net
Payables and other liabilities
MSR related liabilities - nonrecourse at fair value
Total liabilities
Preferred stock at $0.00001 - 10 million shares authorized, zero shares issued, zero shares outstanding; aggregate liquidation preference of zero
Common stock at $0.01 par value - 300 million shares authorized, 93.2 million shares issued
Additional paid-in-capital
Retained earnings
Treasury shares at cost - 29.2 million and 29.6 million shares, respectively
Total stockholders’ equity
Non-controlling interests
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support